Natera, Inc. (NTRA)
NTRANASDAQ-GSMedical Specialities
$313.01
-7.38 (-2.30%) today
Regular session, Nov 10, 3:19 PM ET
- Market cap
- $45.39bn
- P/E
- –
- EPS, last 4 quarters
- $-1.07
- Dividend yield
- –
- Day range
- $307.08 to $323.73
- 52-week range
- $181.00 to $437.41
- Average volume
- 1.78m
- Previous close
- $320.39
Analysts
21 coveringBuy19 buy, 2 hold, 0 sell
Targets a year out average $418.69, +33.8% from here
Earnings
next estimate $0.00000000Next report
Dec 2025
+176.1%
Mar 2026
-5.7%
Jun 2026
0.0%
Sep 2026
-129.4%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $665.50m | $696.64m | $752.75m | $793.98m |
| Gross profit | $445.43m | $450.83m | $485.19m | $513.48m |
| Operating income | -$22.79m | -$93.52m | -$75.79m | -$68.32m |
| Net income | $47.26m | -$85.09m | -$66.97m | -$59.91m |
Last four quarters: revenue $2.91bn, margin -5.7%, free cash flow $52.47m
News
8 latest- ATFV, ZS, NTRA, TWLO: Large Outflows Detected at ETFBNK Invest · 4 hours ago
- Natera, Incyte Launch Phase 2 MRD-Guided Colorectal Cancer Study RTTNews · 7 hours ago
- Natera Q3 Earnings Call Highlights $6B Target & Raised 2026 OutlookZacks · 1 day ago
- NTRA Q3 Loss Wider Than Expected, Revenues Beat, '26 Sales View UpZacks · 1 day ago
- Oversold Conditions For Natera (NTRA)BNK Invest · 4 days ago
- Natera (NTRA) Q3 2026 Earnings Call TranscriptThe Motley Fool · 4 days ago
- Natera, Inc. Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue GuidanceFintel · 4 days ago
- What Natera (NTRA) Said on Its Q3 Earnings CallMarketBeat · 4 days ago
The company
Natera is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are supported by more than 400 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, San Carlos, California, and Boulder, Colorado.
- Sector
- Health Care
- Industry
- Medical Specialities
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- natera.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.